[1]Chen F, Ehlerding E B, Cai W. Theranostic nanoparticles[J]. Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2014, 55(12): 1 919-1922.
[2]Phillips W T , Bao A, Brenner A J ,et al.Image-guided nterventional therapy for cancer with radiotherapeutic nanoparticles[J]. Advanced Drug Delivery Reviews, 2014, (12628): 21.
[3]Mirza A Z, Siddiqui F A. Nanomedicine and drug delivery: a mini review[J]. International Nano Letters, 2014, 4(1): 94.
[4]Marmorato P, Simonelli F, Abbas K,et al. 56Co-labelled radioactive Fe3O4 nanoparticles for in vitro uptake studies on Balb/3T3 and Caco2 cell lines[J]. J Nanopart Res , 2011,13: 6707-6716.
[5]Nijsen F, Rook D, Brandt C, et al.Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study[J]. European Journal of Nuclear Medicine, 2001, 28(6): 743-749 .
[6]Ehlerding E B, Goel S, Cai W.Cancer theranostics with 64Cu/177Lu-loaded liposomes[J]. Eur J Nucl Med Mol Imaging, 2016, 43: 938-940.
[7]Avcba U, Avcba N, Akaln H A, et al. Synthesis and biodistribution of novel magnetic-poly(HEMA-APH) nanopolymer radiolabeled with iodine-131 and investigation its fate in vivo for cancer therapy[J]. Journal of Nanoparticle Research, 2013, 15(10): 1-24.
[8]Hara E, Makino A, Kurihara K, et al. Radionuclide therapy using nanoparticle of 131I Lactosome in combination with percutaneous ethanol injection therapy[J]. Journal of Nanoparticle Research, 2013, 15(15): 1-10.
[9]芮玉奎,张艳北,桂新,等. 金属及金属氧化物纳米材料的放射性标记[J]. 同位素,2013,26(1):8-15.Rui yukui, Zhang yanbei, Gui xin, et al. Radiolabeling of metallic and metal oxide nanomaterials[J]. Journal of Isotopes, 2013, 26(1): 8-15(in Chinese).
[10]Agata P, Edyta L, Frank B, et al. Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy[J]. Journal of Nanoparticle Research, 2013, 15(11): 2082.
[11]Kurihara K, Ueda M, Hara I, et al. Inflammation-induced synergetic enhancement of nanoparticle treatments with DOXIL, and 90Y Lactosome for orthotopic mammary tumor[J]. Journal of Nanoparticle Research, 2016, 18(5): 1-11.
[12]IAEA. Nuclear Technology Review 2013.[EB/OL][2017-05-25]. http:∥www.iaea.org/OurWork/ST/NE/Pess/assets/13-25751_rep_ntr_2013_web.pdf.
[13]Navya P N, Daima H K. Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives.[J]. Nano Convergence, 2016, 3(1): 1.
[14]Ritz S, Kotman N, Baier G, et al. The protein corona of nanoparticles: distinct proteins regulate the cellular uptake[J]. Biomacromolecules, 2015, 16(4): 1 311-21.
[15]Durán N, Silveira C P, Durán M, et al. Silver nanoparticle protein corona and toxicity: a mini-review[J]. Journal of Nanobiotechnology, 2015, 13(1): 55.
[16]Mogharabi M, Abdollahi M, Faramarzi M A. Toxicity of nanomaterials; an undermined issue[J]. Daru Journal of Pharmaceutical Sciences, 2014, 22(1): 59.
[17]Gomes A, Sengupta J, Datta P, et al. Physiological interactions of nanoparticles in energy metabolism, immune function and their biosafety: a review[J]. Journal of Nanoscience & Nanotechnology, 2016, 16(1): 92.
[18]Walsh A A. Chemisorption of iodine-125 to gold nanoparticles allows for real-time quantitation and potential use in nanomedicine[J]. Journal of Nanoparticle Research, 2017, 19(4): 152.
[19]Cedrowska, yczko E, Piotrowska M , et al. Silver impregnated nanoparticles of titanium dioxide as carriers for 211At[J]. Radiochimica Acta, 2016, 104(4): 267-275.
[20]Sunderland K S, Yang M, Mao C. Phage-enabled nanomedicine: from probes to therapeutics in precision medicine[J]. Angewandte Chemie International Edition, 2016, 56(8): 1964.
[21]Hadjidemetriou M, Kostarelos K. Nanomedicine: evolution of the nanoparticle corona[J]. Nature Nanotechnology, 2017: 288-290.
[22]Chen fangfang , Wang guankui , Griffin J I, et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo[J]. Nature Nanotechnology, 2017, 12(4): 387.
[23]Mohammadi M, Ramezani M, Abnous K, et al. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine[J]. International Journal of Pharmaceutics, 2017, 519(1-2): 287.
[24]Muthu M S, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders[J]. Nanomedicine, 2009, 4(1): 105-108. |